Glucose fluctuations in subjects with normal glucose tolerance, impaired glucose regulation and newly diagnosed type 2 diabetes mellitus
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Summary: Objective Glycemic variability is poorly studied in the nondiabetic individuals and newly diagnosed patients with type 2 diabetes. The aim of the study is to investigate the characteristics of glucose fluctuations in subjects with normal glucose tolerance (NGT), impaired glucose regulation (IGR) and newly diagnosed, drug‐naïve type 2 diabetes mellitus (DM‐2). Design and patients This is a cross‐sectional study of three groups including 53 subjects with IGR, 56 DM‐2 patients and 53 NGT individuals. Monitoring by a continuous glucose monitoring system (CGMS® System Gold™) was performed for three consecutive days. Measurements Mean blood glucose (MBG), standard deviation of MBG (SDBG), largest amplitude of glycemic excursions (LAGE) and mean amplitude of glycemic excursions (MAGE) were calculated to estimate intraday blood glucose variability. Interday variability of glucose was evaluated by absolute means of daily differences (MODD). Postprandial glucose excursion (PPGE) was calculated to assess the influence of meals on glucose fluctuation. Results Twenty‐two percentage of NGT and 33·9% of IGR individuals experienced blood glucose ≥11·1 mmol/l; 49·1% of NGT, 50·9% of IGR and 30·8% of DM‐2 participants had hypoglycemic episodes (CGM values <3·9 mmol/l). The IGR and DM‐2 groups had greater SDBG (P = 0·010 and P < 0·001), LAGE (P = 0·014 and P < 0·001) and MAGE (P = 0·044 and P < 0·001) compared with the NGT group. Significantly greater MODD and PPGEs were found in the DM‐2 groups than in the IGR and NGT groups (P < 0·001). The DM‐2 patients had higher 72‐MBG and glucose levels overnight than the NGT and IGR subjects (P < 0·001). In the patients with diabetes, MAGE was positively associated with MODD (r = 0·558, P < 0·001) and PPGEs (r = 0·738–0·843, P < 0·001). Conclusions Glucose variability is present to an increasing degree from NGT to IGR and IGR to DM‐2. Compared with the NGT individuals, the IGR and DM‐2 subjects show more predominant intraday glucose fluctuations. The DM‐2 patients demonstrate increased PPGEs, higher glucose levels overnight and greater interday fluctuations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., & for The STOP-NIDDM Trial Research Group (2003) · JAMA · doi:10.1001/jama.290.4.486 · Cited by 1,624
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes.
Cryer, P. (2002) · Diabetologia · doi:10.1007/s00125-002-0822-9 · Cited by 794
Hypoglycemia in the Diabetes Control and Complications Trial
The Diabetes Control and Complications Trial Research Group (1997) · Diabetes · doi:10.2337/diab.46.2.271 · Cited by 746
Glycemic Variability: A Hemoglobin A1c–Independent Risk Factor for Diabetic Complications
Brownlee, M., & Hirsch, I. B. (2006) · JAMA · doi:10.1001/jama.295.14.1707 · Cited by 482
Evaluating the Accuracy of Continuous Glucose-Monitoring Sensors
Kovatchev, B. P., Gonder-Frederick, L. A., Cox, D. J., & Clarke, W. L. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1922 · Cited by 312
The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications
Ceriello, A. (2003) · Diabetologia · doi:10.1007/s00125-002-0931-5 · Cited by 181
Guettier, J.-M., & Gorden, P. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.09.005 · Cited by 68
on behalf of the ADAG Study Group, Borg, R., Kuenen, J. C., Carstensen, B., Zheng, H., Nathan, D. M., Heine, R. J., Nerup, J., Borch-Johnsen, K., & Witte, D. R. (2010) · Diabetologia · doi:10.1007/s00125-010-1741-9 · Cited by 67
Cited by
Glycemic Variability: How Do We Measure It and Why Is It Important?
Suh, S., & Kim, J. H. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.4.273 · Cited by 439
“Although a certain degree of variability is also observed in subjects with normal glucose tolerance [2], GV is increased in people with diabetes and in people with impaired blood glucose regulation.”
BackgroundVantyghem, M.-C., Raverdy, V., Balavoine, A.-S., Defrance, F., Caiazzo, R., Arnalsteen, L., Gmyr, V., Hazzan, M., Noël, C., Kerr-Conte, J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2115 · Cited by 103
Kessler, K., Hornemann, S., Petzke, K. J., Kemper, M., Kramer, A., Pfeiffer, A. F. H., Pivovarova, O., & Rudovich, N. (2017) · Scientific Reports · doi:10.1038/srep44170 · Cited by 60
Alternative Dietary Patterns for Americans: Low-Carbohydrate Diets
Volek, J. S., Phinney, S. D., Krauss, R. M., Johnson, R. J., Saslow, L. R., Gower, B., Yancy, W. S., King, J. C., Hecht, F. M., Teicholz, N., et al. (2021) · Nutrients · doi:10.3390/nu13103299 · Cited by 57
“Individuals with prediabetes and T2D have greater intraday glycemic variability [96], which may exacerbate oxidative stress and vascular endothelial damage [97].”
BackgroundKang, X., Wang, C., Lifang, L., Chen, D., Yang, Y., Liu, G., Wen, H., Chen, L., He, L., Li, X., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0305 · Cited by 36
“The installation of the CGMS has been previously described.(16) Easy GV version 6.”
MethodSelf-citation
Metadata
- Authors
- Wang, C., Lv, L., Yang, Y., Chen, D., Liu, G., Chen, L., Song, Y., He, L., Li, X., Tian, H., Jia, W., & Ran, X.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2012-04-23
- Volume
- 76
- Issue
- 6
- Pages
- 810-815
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W1492913788
- Cited by
- 94
- References
- 10
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.